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RELEVANCE OF GENOMIC IMPRINTING IN INTRAUTERINE HUMAN GROWTH 




Purpose: Relation of imprinted genes (IGF2, CDKN1C, PHLDA2 and KCNQ1) with human fetal growth. 
 
Methods: RNA was extracted from fetuses with growth restriction and from the control group without growth 
restriction. cDNA synthesis was performed to evaluate the gene expressions patterns of IGF2, CDKN1C, PHLDA2, 
H19 and KCNQ1 genes using RT-PCR. The housekeeping gene GAPDH was used as control. DNA extraction and 
MS-MLPA were also performed to assess the IC1 and IC2 DNA methylation status on chromosome 11p15.5. 
 
Results: The expression levels of IGF2 in the growth restriction group were statistically down-regulated 
(p < 0.0001). Sixty five percent of the cases with IUGR were hypomethylated in IC1.  
 
Conclusions: The genomic imprinting is a phenomenon that plays a very important role in the fetal and placental 
development. Several imprinting genes may regulate this process and despite the several studies performed before 
additional research is still required. This study allows us to stress the importance of IGF2 gene during the pregnancy. 
Hypomethylation of the IC1 on chromosome 15p15.5 and down-regulation of the IGF2 gene seems to be associated 
with intrauterine growth restriction. 
 




Intrauterine growth restriction (IUGR) is a condition in which a fetus is unable to achieve its genetically 
determined potential size thereby increasing their perinatal risk of morbidity and mortality. IUGR encompasses many 
different maternal and fetal causes. Concerning fetal problems, chromosomal abnormalities are one of the major 
causes of growth restriction [1]. Additionally, this phenomenon may happen due to an abnormal gene expression in 
the tissues leading to an abnormal growth of the fetus.  
Epigenetics has a central role in the regulation of fetal growth and development. In particular, imprinted 
genes comprise a small subset of the human genome that has been shown to be essential to fetal, placental and 
behavioral development. Genomic imprinting is characterized by an epigenetic modification in which one allele is 
repressed according to parental origin. In general, paternally expressed genes promote fetal and placental growth 
while maternally expressed genes limits conceptus growth. This is consistent with the imprinting conflict theory, 
which postulates that the paternal genome maximizes extraction of maternal resources for the benefit of the paternal 
offspring while maternal genome limits nutrient provision acting to preserve and distribute such resources more 
equally between all her potential offspring [2-4]. Currently, there are over 90 known human imprinted genes in man 
(http://www.geneimprint.com). Insulin-like growth factor 2 (IGF2) is a paternally expressed gene, which acts as 
growth factor and has been associated with some pathologies such as Beckwith-Wiedmann syndrome (BWS, OMIM: 
#130650), which is characterized among other by an overgrowth [5, 6]. Having the opposite effect, Cyclin-dependent 
kinase inhibitor 1C (CDKN1C) [7], Pleckstrin homology-like domain family A member 2 (PHLDA2) and Potassium 
voltage-gated channel (KCNQ1) are imprinted genes that tend to restrict fetal body’s weight, being associated with 
restriction growth syndromes such as Silver-Russell syndrome (SRS, OMIM: #180860) [8, 9]. All these genes are 
located in the same cluster, on chromosome 11 at p15.5. Two independent imprinting control regions or imprinting 
centers (IC), IC1 and IC2, regulate its expression. IGF2 and H19 imprinting genes are co-localized in the IC1, which 
contains a methylation-sensitive chromatin insulator that is responsible for controlling the access to them. Therefore, 
methylation in the IC1 of the paternal chromosome prevents the biding of the transcription factor CTCF, being H19 
hypermethylated and silenced and allowing the expression of IGF2. On the other hand, in the maternal chromosome, 
the lack of methylation in this region prevents the activation of IGF2 and the presence of the insulator CTCF 
facilitates H19 transcription.  
In humans, deregulation of the IGF2/H19 imprinted region is associated with the overgrowth and tumor 
predisposition-related BWS and with SRS, mainly characterized by pre- and post-natal growth deficiency. 
 IC2 is much larger and responsible for controlling several maternally expressed genes namely CDKN1C, 
KCNQ1 and PHLDA2. It also includes a non-coding KCNQ1OT1 gene that has an antisense orientation with respect 
to the protein-coding gene KCNQ1. In the maternal chromosome, IC2 is methylated, KCNQ1OT1 is not transcribed 
and the flanking imprinted genes are expressed. On the paternal chromosome the IC2 sequence itself and/or the 
KCNQ1OT1 transcript mediate the silence of the several genes of the region including the growth inhibitors 
CDKN1C, PHLDA2 and KCNQ1 genes (Fig 2A) [10-12]. 
Genomic DNA methylation in these ICs may exhibit substantial variation among human individuals. This 
epigenetic variation might contribute either to phenotypic variation, as well as to human disease [12, 13]. Although 
this subject has been the focus of much attention recently, the role of human imprinted genes in fetal development is 
not fully understood. With this study we assess the expression levels of four imprinted genes (IGF2, CDKN1C, 
PHLDA2 and KCNQ1) in fetal and placental samples from spontaneous abortions or fetal deaths in which has been 
identified growth restriction. Additionally, we studied the IC1 and IC2 methylation status on chromosome 11p15.5 in 
the same samples. 
 
 
Materials and Methods 
 
Tissue Samples 
We collected a total of 25 tissue samples from 13 fetuses; 10 of them were diagnosed with growth 
restriction and 3 of them without restriction, forming the control group. The samples were obtained from fetal tissue 
(n=12) and placental tissue (n=13). In the growth restriction group 9/10 cases have paired fetal/placental samples, 
while in the control group this is seen in 2/3 cases. The cases resulted from spontaneous miscarriage or fetal death in 
which has been identified growth restriction. The controls were selected from those with an infectious cause 
identified.  
All samples were from fetus in the second trimester, with a gestational age between 14 and 24 weeks. 
The samples were collected in RNA later and stored at -80ºC until use. Only cases with normal karyotype 
were used in our study. 
The experimental plan was approved by the ethical committee of Centro Hospitalar de São João, EPE. 
 
 
RNA extraction and cDNA synthesis 
Total RNA was extracted from samples using 1ml of Tripure Isolation Reagent (Roche, Diagnostics, 
Indianapolis, IN, USA) according to the manufacturer’s standard protocol. Quantification and purity were 
determined by NanoDrop 2000 UV-Vis Spectrophotometer (Nanodrop Technologies, Wilmington, USA). For cDNA 
synthesis, 10µg of total RNA was subjected to reverse transcription using qScriptTM cDNA Synthesis Kit (Quanta 
BioSciences, Inc., Gaithersburg, USA) following the manufacturer’s instructions.  
 
Quantitative RT-PCR 
RNA expression levels of four imprinted genes (CDKN1C, IGF2, KCNQ1 and PHLDA2) and one 
housekeeping gene (GADPH) were analyzed by Real-Time PCR on a StepOnePlus™ Real-Time PCR System (Life 
Technologies Corporation, California, USA). Taqman® Gene Expression Assays (Life Technologies Corporation, 
California, USA) were used for each target gene CDKN1C (Hs00175938_m1), IGF2 (Hs01005963_m1), KCNQ1 
(Hs00923522_m1) and PHLDA2 (Hs00169368_m1), and endogenous control GAPDH (Hs99999905_m1). PCR 
reactions were performed in a 25 µl volume containing 5 µl of cDNA, 12.5 µl of TaqMan® Universal PCR Master 
Mix System (Life Technologies Corporation, California, USA), 6.25 µl of Rnase-free water and 1.25 µl of 20X 
TaqMan ® Gene Expression Assay Mix for each gene. PCR was performed in separated wells for each reaction and 
each sample was run in triplicate. For each gene, cases and controls samples were run in the same RT-PCR plate to 
minimize intra-plate variations. PCR parameters were as follows: 50°C for 2 min, 95°C for 10 min, followed by 40 
cycles at 95°C for 15 s and 60°C for 1 min. In each plate negative controls were included. 
 
DNA extraction and MS-MLPA 
DNA extraction was performed according to the manufacturer’s standard protocol using the DNeasy 
Blood & Tissue kit (Qiagen, Hilden, Germany). 
Afterward, MS-MLPA was performed on genomic DNA with SALSA MS-MLPA kit ME030-C1 
BWS/SRS, (MRC-Holland, Amsterdam, The Nederland’s), according to the manufacturer’s instructions. This mix 
contains 42 probes, 26 of which for the region 11p.15. The methylation status of this region can also be determined 
by 10 of these probes since they contain an HhaI recognition site. In addition, further 15 probes are added for 
reference.  
After 16 h of hybridization at 60ºC, samples were equally split into two aliquots. The first aliquot 
underwent ligation only, whereas the second one underwent ligation followed by enzymatic digestion with HhaI (a 
restriction enzyme recognizing only unmethylated DNA) and PCR amplification using universal primers. In the latter 
case, amplification products were obtained and detected by capillary electrophoresis only if the CpG included in the 
HhaI site was methylated and, therefore, not digested. Ligation, enzymatic digestion, and PCR amplification were 
performed according to the manufacturer’s instructions. PCR products (1 ml) were mixed with 0.3 ml of internal size 
standard (GeneScan™ 600 LIZ; Applied Biosystems) and 13,7 ml of deionized formamide, and injected into 3500 
Genetic Analyzer (Life Technologies Corporation, California, USA). 
 
Data Analysis 
Gene Expression Values 
The results were treated using the validated Livak method [14].  
A mean was calculated between the 3 replicates for the reference gene and the target gene. The value of 
threshold cycle (CT) of the target gene was deducted to that of reference (ref) or housekeeping gene, for the test 
samples [ΔCT (sample) = CT (ref) – CT (target gene)]. Later, the expression ratio was considered by calculating the 
normalized expression (2-ΔCT = normalized expression ratio) 
The result obtained of the target gene in the sample was therefore normalized to the expression of a 
reference gene. Normalizing the expression of the target gene to that of the reference gene compensates for any 
difference in the amount of the sample cDNA. 
 
MS-MLPA  
Each probe’s signal was divided by the signal of each reference probe in the sample. After, the median of 
these ratios was estimated, so called Normalization Constant (NC). This value was divided by the average NC 
obtained in the undigested reference samples. Values ranging from 0.65 to 1.35 were considered as having normal 
number copies (diploid); a deletion was suspected for ratio less than 0.65 and a duplication was suspected for ratio 
more than 1.35. Quantification of the methylation status of a CpG site was done by dividing the NC of each MS-
MLPA probe obtained on the digested aliquot by the NC of each MS-MLPA probe obtained on the corresponding 
undigested aliquot. To simplify the interpretation of data, we calculated the average methylation status obtained by 
the H19 and KCNQ1OT1 probes and indicated them as IC1 and IC2 methylation index, respectively. Due to our 
reduced numbers of controls, previous published data was used for the determination of the normal methylation 
levels ranges, so the mean methylation indices for normal samples used were 0.52 (range 0.47-0.58) for IC2 and 0.50 
(range 0.46-0.55) for IC1 [11]. 
Results 
 
RT-PCR Expression Profile 
A total of 20 cDNA samples derived from fetuses diagnosed with growth restriction and 5 cDNA samples 
derived from healthy fetuses (control group) were analyzed by RT-PCR for gene expression quantification (Fig. 1). 
The results indicate that the expression levels of IGF2 in the growth restriction group were statistically down-
regulated (p < 0.0001). The expression profiles for the other studied genes showed no statistical difference.  
 
DNA methylation analysis 
A total of 25 DNA samples derived from fetuses diagnosed with growth restriction (n=20) and from 
healthy fetuses, control group (n=5), were analyzed to evaluate the methylation status. The results are summarized in 
Table 1. No copy number alterations were found. 
Four out of 20 samples with growth restriction presented a normal methylation status in the IC1, 13 out of 
20 had IC1 hypomethylation and 3 out of 20 had IC1 hypermethylated. In the control group one sample out of 5 
presented a normal methylation status in the IC1, and 4 out of 5 had IC1 hypermethylated. 
Regarding IC2 in the growth restriction group, a normal methylation status was detected in 11 out of 20 
samples, 8 out of 20 had IC2 hypomethylation and 1 out of 20 had IC2 hypermethylation. In the control group 1 out 





IUGR comprises one of the leading obstetric complications, indicating the presence of a pathophysiologic 
process occurring in utero that inhibits fetal growth. This regulation involves multiple factors with complex 
mechanisms. In order to better elucidate this process we studied four imprinted genes, CDKN1C, IGF2, KCNQ1 and 
PHLDA2, since they play an important role in this area. Therefore, mRNA expression of these imprinted genes in 
IUGR and controls cases was analyzed.  
The results from the mRNA expression studies indicated that IGF2 gene levels were downregulated in the 
IUGR group. The expression profiles of the other genes showed no statistical difference. Regarding IGF2, the 
majority of reports have focused on evaluation of the expression level change in the fetal/placental unit, in 
association with intrauterine growth defects. In spite of some conflicting evidence regarding downregulation levels in 
the placenta of IUGR, some authors describe decreased expression in association with intrauterine growth restriction 
[15-18]. Sibley et al., reported downregulation of IGF2 in cases with IUGR placenta versus normal term placenta, 
albeit with greater case-to-case variability [16]. In mouse, mutations in igf2 gene lead to IUGR [19].  
IGF2 is considered the major fetal growth factor that regulates fetal/placental growth by stimulating 
trophoblastic migration and invasion. It also regulates diffusional exchange characteristics of the placenta. Although, 
intrauterine growth restriction is an extremely complex phenomenon, other genes and processes could contribute for 
this particular condition [2].  
In this study, we did not find statistical differences between the two groups referred above in respect to the 
other three genes included in the study. Nevertheless, in a previous study done by our group, we observed an 
increase in the PHLDA2 expression levels gene associated with spontaneous abortions, in the first trimester, and with 
IUGR in second trimester cases, although not very significant [20]. It is important to stress that it has also been 
suggested that PHLDA2 gene may have a more profound effect on the placenta at early gestational ages when the 
placenta is more active, which is also in accordance with our previous report [18, 20]. 
Additionally to the mRNA expression levels, the study of the IC1 and IC2 methylation status was carried 
out in order to evaluate if abnormalities in these imprinting centres could be related with the IUGR. MS-MLPA was 
used for this study because it was already demonstrated that is a very specific and sensitive method, allowing the 
detection of both copy number and methylation level of the investigated loci [11]. 
H19 and IGF2 share common enhancers located downstream of H19. IC1 prevents IGF2 expression from 
the maternal allele but allows its expression from the paternal allele, due to the DNA methylation mark at IC1. This 
epigenetic mark is extended to the H19 promoter on the paternal allele, restricting H19 expression to the maternal 
chromosome. Sixty percent of SRS cases are associated with loss of DNA methylation (LOM) from the paternal IC1 
allele [8]. This defect represents a maternalization of IC1; this means that the methylated paternal allele acquires a 
maternal epigenotype (Fig. 2A and B). Consequently, it is expected a decrease of IGF2 expression and/or an increase 
in H19 expression and this may be associated with growth restriction, which is one of the main characteristics of the 
SRS phenotype. The same molecular defect can be applied to IUGR cases. 
 Our results showed that 65% of the cases with IUGR were hypomethylated in IC1. This means that IC1 
hypomethylation could be one of the possible explanations for the fetal growth restriction.  
Several studies revealed IC1/IC2 epimutations in patients with SRS. In one study MS-MLPA performed in 
peripheral blood from three patients referred as SRS revealed hypomethylation in both IC1 and IC2 but when the 
study was performed using buccal cells only the hypomethylation of the IC1 was confirmed [21]. This means that 
different tissues can have different methylations ranges. In present study we used fetal and placental tissues from 
IUGR cases, however due to small number of cases it was not possible to compare these different tissues. It will be 
very important to enlarge the series of IUGR cases, assessing different tissues (fetal and placental) and also 
extending the study to the third trimester of pregnancy.  
In the present study, hypomethylation of IC2 was also observed for 40% of the samples. Begemann et al. 
and Azzi et al. found 3.8% and 4.05% of SRS cases with IC2 hypomethylation, in previous studies, respectively [21, 
22]. The specific reason for the development of IUGR is not clear, nevertheless mosaicism could explain variability, 
and the loss of paternal or maternal methylation marks could probably not only be attributed to a deficient 
acquisition of methylation during gametogenesis but be consistent with an incorrect maintenance of methylation after 
fertilization. Spontaneous abortions cases could reflect more severe cases with extreme methylation variations. 
 In conclusion, several factors can affect fetal growth as maternal nutritional status, diet and exposure to 
environmental factors. This leads to an alteration in nutrient availability to the fetus and to a modulation of placental 
gene expression [15]. Imprinted genes can be responsible for IUGR, but more other non-imprinted genes may be 
involved [2]. 
It would be interesting to compare our data from the second trimester with data from the third trimester 
and assess whether there are differences throughout gestation.  
More research is needed in this field, because there is not much knowledge about imprinting gene 
regulation, as well as their proper role in placental and human fetal growth. The possibility to early identification of 
differences in the methylation ranges (i.e. hypomethylation of IC1 using MS-MLPA) could be used to identify 
pregnancies with higher risk of severe IUGR.  
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Fig.%1:%Expression% levels%of% the% studied%genes.% cDNA%expression%was%normalized%using%a%housekeeping%gene%(GAPDH).%Error%bars%represents%standard%error%of%the%mean%(SEM).%Significant%differences%between%groups%are%represented%as:%*%p<%0.0001.%The%data%was%analysed%by%Student’s%tKtest.%GR%–%Growth%Restriction.%
 
 
Fig. 2: Regulation of imprinted genes expression according to IC1/IC2 methylation, both in paternal (pat) and 
maternal (mat) chromosomes; (A) – Epigenotypes of normal imprinted gene expression, (B) – Epigenetic 
abnormalities often detected in SRS patients, representing maternalization of IC1. 
  







 (M!± SD) 
IC2 
Nº Samples  
(M!± SD) 
Growth Restriction  
Normal 4 (51.9 ± 1.7) 11 (51.4 ± 3.3) 
Hypomethylated 13 (37.5 ± 4.5) 8 (40.4 ± 7.7) 
Hypermethylated 3 (60.0 ± 5.7) 1 (58.2) 
Controls 
Normal 1 (51.6) 1 (56.3) 
Hypomethylated 0 (0) 0 (0) 
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approved  by  all  co-­authors,  if  any,  as  well  as  by  the  responsible  authorities  –  tacitly  or  explicitly
–  at  the  institute  where  the  work  has  been  carried  out.  The  publisher  will  not  be  held  legally
responsible  should  there  be  any  claims  for  compensation.
Authors  wishing  to  include  figures,  tables,  or  text  passages  that  have  already  been  published
elsewhere  are  required  to  obtain  permission  from  the  copyright  owner(s)  for  both  the  print  and
online  format  and  to  include  evidence  that  such  permission  has  been  granted  when  submitting
their  papers.  Any  material  received  without  such  evidence  will  be  assumed  to  originate  from
the  authors.
Authors  should  submit  their  manuscripts  online.  Electronic  submission  substantially  reduces
the  editorial  processing  and  reviewing  times  and  shortens  overall  publication  times.  Please
follow  the  hyperlink  “Submit  online”  on  the  right  and  upload  all  of  your  manuscript  files
following  the  instructions  given  on  the  screen.
TITLE  PAGE
The  title  page  should  include:
The  name(s)  of  the  author(s)
A  concise  and  informative  title
The  affiliation(s)  and  address(es)  of  the  author(s)
The  e-­mail  address,  telephone  and  fax  numbers  of  the  corresponding  author
Please  provide  a  structured  abstract  of  150  to  250  words  which  should  be  divided  into  the
following  sections:




Please  provide  4  to  6  keywords  which  can  be  used  for  indexing  purposes.
TEXT
Manuscripts  should  be  submitted  in  Word.
Use  a  normal,  plain  font  (e.g.,  10-­point  Times  Roman)  for  text.
Use  italics  for  emphasis.
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LaTeX  macro  package  (zip,  182  kB)
Use  the  automatic  page  numbering  function  to  number  the  pages.
Do  not  use  field  functions.
Use  tab  stops  or  other  commands  for  indents,  not  the  space  bar.
Use  the  table  function,  not  spreadsheets,  to  make  tables.
Use  the  equation  editor  or  MathType  for  equations.
Save  your  file  in  docx  format  (Word  2007  or  higher)  or  doc  format  (older  Word
versions).
Manuscripts  with  mathematical  content  can  also  be  submitted  in  LaTeX.
Please  use  no  more  than  three  levels  of  displayed  headings.
Abbreviations  should  be  defined  at  first  mention  and  used  consistently  thereafter.
Footnotes  can  be  used  to  give  additional  information,  which  may  include  the  citation  of  a
reference  included  in  the  reference  list.  They  should  not  consist  solely  of  a  reference  citation,
and  they  should  never  include  the  bibliographic  details  of  a  reference.  They  should  also  not
contain  any  figures  or  tables.
Footnotes  to  the  text  are  numbered  consecutively;;  those  to  tables  should  be  indicated  by
superscript  lower-­case  letters  (or  asterisks  for  significance  values  and  other  statistical  data).
Footnotes  to  the  title  or  the  authors  of  the  article  are  not  given  reference  symbols.
Always  use  footnotes  instead  of  endnotes.
Acknowledgments  of  people,  grants,  funds,  etc.  should  be  placed  in  a  separate  section  before
the  reference  list.  The  names  of  funding  organizations  should  be  written  in  full.
SCIENTIFIC  STYLE
Generic  names  of  drugs  and  pesticides  are  preferred;;  if  trade  names  are  used,  the  generic
name  should  be  given  at  first  mention.
REFERENCES
Reference  citations  in  the  text  should  be  identified  by  numbers  in  square  brackets.  Some
examples:
1.  Negotiation  research  spans  many  disciplines  [3].
2.  This  result  was  later  contradicted  by  Becker  and  Seligman  [5].
3.  This  effect  has  been  widely  studied  [1-­3,  7].
The  list  of  references  should  only  include  works  that  are  cited  in  the  text  and  that  have  been
published  or  accepted  for  publication.  Personal  communications  and  unpublished  works
should  only  be  mentioned  in  the  text.  Do  not  use  footnotes  or  endnotes  as  a  substitute  for  a
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EndNote  style  (zip,  3  kB)
reference  list.
The  entries  in  the  list  should  be  numbered  consecutively.
Journal  article
Smith  JJ.  The  world  of  science.  Am  J  Sci.  1999;;36:234–5.
Article  by  DOI
Slifka  MK,  Whitton  JL.  Clinical  implications  of  dysregulated  cytokine  production.  J
Mol  Med.  2000;;  doi:10.1007/s001090000086
Book
Blenkinsopp  A,  Paxton  P.  Symptoms  in  the  pharmacy:  a  guide  to  the  management
of  common  illness.  3rd  ed.  Oxford:  Blackwell  Science;;  1998.
Book  chapter
Wyllie  AH,  Kerr  JFR,  Currie  AR.  Cell  death:  the  significance  of  apoptosis.  In:  Bourne
GH,  Danielli  JF,  Jeon  KW,  editors.  International  review  of  cytology.  London:
Academic;;  1980.  pp.  251–306.
Online  document
Doe  J.  Title  of  subordinate  document.  In:  The  dictionary  of  substances  and  their
effects.  Royal  Society  of  Chemistry.  1999.  http://www.rsc.org/dose/title  of
subordinate  document.  Accessed  15  Jan  1999.
Always  use  the  standard  abbreviation  of  a  journal’s  name  according  to  the  ISSN  List  of  Title
Word  Abbreviations,  see
www.issn.org/2-­22661-­LTWA-­online.php
For  authors  using  EndNote,  Springer  provides  an  output  style  that  supports  the  formatting  of  in-­
text  citations  and  reference  list.
TABLES
All  tables  are  to  be  numbered  using  Arabic  numerals.
Tables  should  always  be  cited  in  text  in  consecutive  numerical  order.
For  each  table,  please  supply  a  table  caption  (title)  explaining  the  components  of
the  table.
Identify  any  previously  published  material  by  giving  the  original  source  in  the  form
of  a  reference  at  the  end  of  the  table  caption.
Footnotes  to  tables  should  be  indicated  by  superscript  lower-­case  letters  (or
asterisks  for  significance  values  and  other  statistical  data)  and  included  beneath
the  table  body.
ARTWORK  AND  ILLUSTRATIONS  GUIDELINES
For  the  best  quality  final  product,  it  is  highly  recommended  that  you  submit  all  of  your  artwork  –
photographs,  line  drawings,  etc.  –  in  an  electronic  format.  Your  art  will  then  be  produced  to  the
highest  standards  with  the  greatest  accuracy  to  detail.  The  published  work  will  directly  reflect
the  quality  of  the  artwork  provided.
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Supply  all  figures  electronically.
Indicate  what  graphics  program  was  used  to  create  the  artwork.
For  vector  graphics,  the  preferred  format  is  EPS;;  for  halftones,  please  use  TIFF
format.  MS  Office  files  are  also  acceptable.
Vector  graphics  containing  fonts  must  have  the  fonts  embedded  in  the  files.
Name  your  figure  files  with  "Fig"  and  the  figure  number,  e.g.,  Fig1.eps.
Definition:  Black  and  white  graphic  with  no  shading.
Do  not  use  faint  lines  and/or  lettering  and  check  that  all  lines  and  lettering  within
the  figures  are  legible  at  final  size.
All  lines  should  be  at  least  0.1  mm  (0.3  pt)  wide.
Scanned  line  drawings  and  line  drawings  in  bitmap  format  should  have  a  minimum
resolution  of  1200  dpi.
Vector  graphics  containing  fonts  must  have  the  fonts  embedded  in  the  files.
Definition:  Photographs,  drawings,  or  paintings  with  fine  shading,  etc.
If  any  magnification  is  used  in  the  photographs,  indicate  this  by  using  scale  bars
within  the  figures  themselves.
Halftones  should  have  a  minimum  resolution  of  300  dpi.
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Definition:  a  combination  of  halftone  and  line  art,  e.g.,  halftones  containing  line
drawing,  extensive  lettering,  color  diagrams,  etc.
Combination  artwork  should  have  a  minimum  resolution  of  600  dpi.
Color  art  is  free  of  charge  for  online  publication.
If  black  and  white  will  be  shown  in  the  print  version,  make  sure  that  the  main
information  will  still  be  visible.  Many  colors  are  not  distinguishable  from  one
another  when  converted  to  black  and  white.  A  simple  way  to  check  this  is  to  make  a
xerographic  copy  to  see  if  the  necessary  distinctions  between  the  different  colors
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are  still  apparent.
If  the  figures  will  be  printed  in  black  and  white,  do  not  refer  to  color  in  the  captions.
Color  illustrations  should  be  submitted  as  RGB  (8  bits  per  channel).
To  add  lettering,  it  is  best  to  use  Helvetica  or  Arial  (sans  serif  fonts).
Keep  lettering  consistently  sized  throughout  your  final-­sized  artwork,  usually  about
2–3  mm  (8–12  pt).
Variance  of  type  size  within  an  illustration  should  be  minimal,  e.g.,  do  not  use  8-­pt
type  on  an  axis  and  20-­pt  type  for  the  axis  label.
Avoid  effects  such  as  shading,  outline  letters,  etc.
Do  not  include  titles  or  captions  within  your  illustrations.
All  figures  are  to  be  numbered  using  Arabic  numerals.
Figures  should  always  be  cited  in  text  in  consecutive  numerical  order.
Figure  parts  should  be  denoted  by  lowercase  letters  (a,  b,  c,  etc.).
If  an  appendix  appears  in  your  article  and  it  contains  one  or  more  figures,  continue
the  consecutive  numbering  of  the  main  text.  Do  not  number  the  appendix  figures,
"A1,  A2,  A3,  etc."  Figures  in  online  appendices  (Electronic  Supplementary  Material)
should,  however,  be  numbered  separately.
Each  figure  should  have  a  concise  caption  describing  accurately  what  the  figure
depicts.  Include  the  captions  in  the  text  file  of  the  manuscript,  not  in  the  figure  file.
Figure  captions  begin  with  the  term  Fig.  in  bold  type,  followed  by  the  figure  number,
also  in  bold  type.
No  punctuation  is  to  be  included  after  the  number,  nor  is  any  punctuation  to  be
placed  at  the  end  of  the  caption.
Identify  all  elements  found  in  the  figure  in  the  figure  caption;;  and  use  boxes,  circles,
etc.,  as  coordinate  points  in  graphs.
Identify  previously  published  material  by  giving  the  original  source  in  the  form  of  a
reference  citation  at  the  end  of  the  figure  caption.
When  preparing  your  figures,  size  figures  to  fit  in  the  column  width.
For  most  journals  the  figures  should  be  39  mm,  84  mm,  129  mm,  or  174  mm  wide
and  not  higher  than  234  mm.
For  books  and  book-­sized  journals,  the  figures  should  be  80  mm  or  122  mm  wide
and  not  higher  than  198  mm.
If  you  include  figures  that  have  already  been  published  elsewhere,  you  must  obtain
permission  from  the  copyright  owner(s)  for  both  the  print  and  online  format.  Please  be  aware
that  some  publishers  do  not  grant  electronic  rights  for  free  and  that  Springer  will  not  be  able  to
refund  any  costs  that  may  have  occurred  to  receive  these  permissions.  In  such  cases,  material
from  other  sources  should  be  used.
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In  order  to  give  people  of  all  abilities  and  disabilities  access  to  the  content  of  your  figures,
please  make  sure  that
All  figures  have  descriptive  captions  (blind  users  could  then  use  a  text-­to-­speech
software  or  a  text-­to-­Braille  hardware)
Patterns  are  used  instead  of  or  in  addition  to  colors  for  conveying  information
(color-­blind  users  would  then  be  able  to  distinguish  the  visual  elements)
Any  figure  lettering  has  a  contrast  ratio  of  at  least  4.5:1
ARTWORK  AND  ILLUSTRATIONS  GUIDELINES
For  the  best  quality  final  product,  it  is  highly  recommended  that  you  submit  all  of  your  artwork  –
photographs,  line  drawings,  etc.  –  in  an  electronic  format.  Your  art  will  then  be  produced  to  the
highest  standards  with  the  greatest  accuracy  to  detail.  The  published  work  will  directly  reflect
the  quality  of  the  artwork  provided.
Supply  all  figures  electronically.
Indicate  what  graphics  program  was  used  to  create  the  artwork.
For  vector  graphics,  the  preferred  format  is  EPS;;  for  halftones,  please  use  TIFF
format.  MS  Office  files  are  also  acceptable.
Vector  graphics  containing  fonts  must  have  the  fonts  embedded  in  the  files.
Name  your  figure  files  with  "Fig"  and  the  figure  number,  e.g.,  Fig1.eps.
Definition:  Black  and  white  graphic  with  no  shading.
Do  not  use  faint  lines  and/or  lettering  and  check  that  all  lines  and  lettering  within
the  figures  are  legible  at  final  size.
All  lines  should  be  at  least  0.1  mm  (0.3  pt)  wide.
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Scanned  line  drawings  and  line  drawings  in  bitmap  format  should  have  a  minimum
resolution  of  1200  dpi.
Vector  graphics  containing  fonts  must  have  the  fonts  embedded  in  the  files.
Definition:  Photographs,  drawings,  or  paintings  with  fine  shading,
etc.
If  any  magnification  is  used  in  the  photographs,  indicate  this  by
using  scale  bars  within  the  figures  themselves.
Halftones  should  have  a  minimum  resolution  of  300  dpi.
Definition:  a  combination  of  halftone  and  line  art,  e.g.,  halftones  containing  line
drawing,  extensive  lettering,  color  diagrams,  etc.
Combination  artwork  should  have  a  minimum  resolution  of  600  dpi.
Color  art  is  free  of  charge  for  online  publication.
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If  black  and  white  will  be  shown  in  the  print  version,  make  sure  that  the  main
information  will  still  be  visible.  Many  colors  are  not  distinguishable  from  one
another  when  converted  to  black  and  white.  A  simple  way  to  check  this  is  to  make  a
xerographic  copy  to  see  if  the  necessary  distinctions  between  the  different  colors
are  still  apparent.
If  the  figures  will  be  printed  in  black  and  white,  do  not  refer  to  color  in  the  captions.
Color  illustrations  should  be  submitted  as  RGB  (8  bits  per  channel).
To  add  lettering,  it  is  best  to  use  Helvetica  or  Arial  (sans  serif  fonts).
Keep  lettering  consistently  sized  throughout  your  final-­sized  artwork,  usually  about
2–3  mm  (8–12  pt).
Variance  of  type  size  within  an  illustration  should  be  minimal,  e.g.,  do  not  use  8-­pt
type  on  an  axis  and  20-­pt  type  for  the  axis  label.
Avoid  effects  such  as  shading,  outline  letters,  etc.
Do  not  include  titles  or  captions  within  your  illustrations.
All  figures  are  to  be  numbered  using  Arabic  numerals.
Figures  should  always  be  cited  in  text  in  consecutive  numerical  order.
Figure  parts  should  be  denoted  by  lowercase  letters  (a,  b,  c,  etc.).
If  an  appendix  appears  in  your  article  and  it  contains  one  or  more  figures,  continue
the  consecutive  numbering  of  the  main  text.  Do  not  number  the  appendix  figures,
"A1,  A2,  A3,  etc."  Figures  in  online  appendices  (Electronic  Supplementary  Material)
should,  however,  be  numbered  separately.
Each  figure  should  have  a  concise  caption  describing  accurately  what  the  figure
depicts.  Include  the  captions  in  the  text  file  of  the  manuscript,  not  in  the  figure  file.
Figure  captions  begin  with  the  term  Fig.  in  bold  type,  followed  by  the  figure  number,
also  in  bold  type.
No  punctuation  is  to  be  included  after  the  number,  nor  is  any  punctuation  to  be
placed  at  the  end  of  the  caption.
Identify  all  elements  found  in  the  figure  in  the  figure  caption;;  and  use  boxes,  circles,
etc.,  as  coordinate  points  in  graphs.
Identify  previously  published  material  by  giving  the  original  source  in  the  form  of  a
reference  citation  at  the  end  of  the  figure  caption.
When  preparing  your  figures,  size  figures  to  fit  in  the  column  width.
For  most  journals  the  figures  should  be  39  mm,  84  mm,  129  mm,  or  174  mm  wide
and  not  higher  than  234  mm.
For  books  and  book-­sized  journals,  the  figures  should  be  80  mm  or  122  mm  wide
and  not  higher  than  198  mm.
If  you  include  figures  that  have  already  been  published  elsewhere,  you  must  obtain
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permission  from  the  copyright  owner(s)  for  both  the  print  and  online  format.  Please  be  aware
that  some  publishers  do  not  grant  electronic  rights  for  free  and  that  Springer  will  not  be  able  to
refund  any  costs  that  may  have  occurred  to  receive  these  permissions.  In  such  cases,  material
from  other  sources  should  be  used.
In  order  to  give  people  of  all  abilities  and  disabilities  access  to  the  content  of  your  figures,
please  make  sure  that
All  figures  have  descriptive  captions  (blind  users  could  then  use  a  text-­to-­speech
software  or  a  text-­to-­Braille  hardware)
Patterns  are  used  instead  of  or  in  addition  to  colors  for  conveying  information
(color-­blind  users  would  then  be  able  to  distinguish  the  visual  elements)
Any  figure  lettering  has  a  contrast  ratio  of  at  least  4.5:1
ELECTRONIC  SUPPLEMENTARY  MATERIAL
Springer  accepts  electronic  multimedia  files  (animations,  movies,  audio,  etc.)  and  other  supplementary
files  to  be  published  online  along  with  an  article  or  a  book  chapter.  This  feature  can  add  dimension  to
the  author's  article,  as  certain  information  cannot  be  printed  or  is  more  convenient  in  electronic  form.
Supply  all  supplementary  material  in  standard  file  formats.
Please  include  in  each  file  the  following  information:  article  title,  journal  name,  author
names;;  affiliation  and  e-­mail  address  of  the  corresponding  author.
To  accommodate  user  downloads,  please  keep  in  mind  that  larger-­sized  files  may  require
very  long  download  times  and  that  some  users  may  experience  other  problems  during
downloading.
Always  use  MPEG-­1  (.mpg)  format.
Submit  your  material  in  PDF  format;;  .doc  or  .ppt  files  are  not  suitable  for  long-­term  viability.
A  collection  of  figures  may  also  be  combined  in  a  PDF  file.
Spreadsheets  should  be  converted  to  PDF  if  no  interaction  with  the  data  is  intended.
If  the  readers  should  be  encouraged  to  make  their  own  calculations,  spreadsheets  should
be  submitted  as  .xls  files  (MS  Excel).
Specialized  format  such  as  .pdb  (chemical),  .wrl  (VRML),  .nb  (Mathematica  notebook),  and
.tex  can  also  be  supplied.
It  is  possible  to  collect  multiple  files  in  a  .zip  or  .gz  file.
If  supplying  any  supplementary  material,  the  text  must  make  specific  mention  of  the  material
as  a  citation,  similar  to  that  of  figures  and  tables.
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Refer  to  the  supplementary  files  as  “Online  Resource”,  e.g.,  "...  as  shown  in  the  animation
(Online  Resource  3)",  “...  additional  data  are  given  in  Online  Resource  4”.
Name  the  files  consecutively,  e.g.  “ESM_3.mpg”,  “ESM_4.pdf”.
For  each  supplementary  material,  please  supply  a  concise  caption  describing  the  content  of
the  file.
Electronic  supplementary  material  will  be  published  as  received  from  the  author  without  any
conversion,  editing,  or  reformatting.
In  order  to  give  people  of  all  abilities  and  disabilities  access  to  the  content  of  your  supplementary  files,
please  make  sure  that
The  manuscript  contains  a  descriptive  caption  for  each  supplementary  material
Video  files  do  not  contain  anything  that  flashes  more  than  three  times  per  second  (so  that
users  prone  to  seizures  caused  by  such  effects  are  not  put  at  risk)
INTEGRITY  OF  RESEARCH  AND  REPORTING
Manuscripts  submitted  for  publication  must  contain  a  statement  to  the  effect  that  all  human  and  animal
studies  have  been  approved  by  the  appropriate  ethics  committee  and  have  therefore  been  performed
in  accordance  with  the  ethical  standards  laid  down  in  the  1964  Declaration  of  Helsinki  and  its  later
amendments.
It  should  also  be  stated  clearly  in  the  text  that  all  persons  gave  their  informed  consent  prior  to  their
inclusion  in  the  study.  Details  that  might  disclose  the  identity  of  the  subjects  under  study  should  be
omitted.
The  editors  reserve  the  right  to  reject  manuscripts  that  do  not  comply  with  the  above-­mentioned
requirements.  The  author  will  be  held  responsible  for  false  statements  or  failure  to  fulfill  the  above-­
mentioned  requirements
All  benefits  in  any  form  from  a  commercial  party  related  directly  or  indirectly  to  the  subject  of  this
manuscript  or  any  of  the  authors  must  be  acknowledged.  For  each  source  of  funds,  both  the  research
funder  and  the  grant  number  should  be  given.  This  note  should  be  added  in  a  separate  section  before
the  reference  list.
If  no  conflict  exists,  authors  should  state:  The  authors  declare  that  they  have  no  conflict  of  interest.
DOES  SPRINGER  PROVIDE  ENGLISH  LANGUAGE  SUPPORT?
Manuscripts  that  are  accepted  for  publication  will  be  checked  by  our  copyeditors  for  spelling  and
formal  style.  This  may  not  be  sufficient  if  English  is  not  your  native  language  and  substantial  editing
would  be  required.  In  that  case,  you  may  want  to  have  your  manuscript  edited  by  a  native  speaker  prior
to  submission.  A  clear  and  concise  language  will  help  editors  and  reviewers  concentrate  on  the
scientific  content  of  your  paper  and  thus  smooth  the  peer  review  process.
The  following  editing  service  provides  language  editing  for  scientific  articles  in  all  areas  Springer
publishes  in.
Use  of  an  editing  service  is  neither  a  requirement  nor  a  guarantee  of  acceptance  for  publication.
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